Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 12.32MWorking Capital
VS
Market
Sector
Industry
History
$ 4.37Close
$ 2.58 - $ 5.4 52-Week Range
Ticker Information
Ticker
LTRNCompany Name
LANTERN PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLANTERN PHARMA INC - Working Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LTRN - Working Capital Historical data
| Date | Current Assets | Current Liabilities | Working Capital |
|---|---|---|---|
| 6/30/2025 | $ 17.2M | $ 4.88M | $ 12.32M |
| 3/31/2025 | $ 20.82M | $ 4.29M | $ 16.54M |
| 12/31/2024 | $ 25.25M | $ 4.33M | $ 20.92M |
| 9/30/2024 | $ 29.92M | $ 3.6M | $ 26.32M |
| 6/30/2024 | $ 35.29M | $ 4.6M | $ 30.69M |
| 3/31/2024 | $ 39.47M | $ 3.95M | $ 35.52M |
| 12/31/2023 | $ 43.34M | $ 2.68M | $ 40.66M |
| 9/30/2023 | $ 47.43M | $ 2.25M | $ 45.17M |
| 6/30/2023 | $ 51.04M | $ 3.02M | $ 48.03M |
| 3/31/2023 | $ 55.17M | $ 2.79M | $ 52.37M |
Key Performance Insights, Last 5 Years
- LANTERN PHARMA INC's latest trailing twelve months (TTM) Working Capital stands at $ 21.66M.
- Over the past 5 years, LANTERN PHARMA INC's average Working Capital has been $ 45.79M.
- The median Working Capital for LANTERN PHARMA INC during this period was $ 46.6M
- LANTERN PHARMA INC reached its highest Working Capital over the past 5 years at $ 81.82M.
- The lowest Working Capital recorded by LANTERN PHARMA INC in the same timeframe $ 12.32M
Similar metrics to Working Capital:
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Working Capital
[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].AssetsC - LiabilitesC
(=) Working Capital Working Capital for LANTERN PHARMA INC is calculated as follows: AssetsC [ $ 22.48M ] - LiabilitesC [ $ 814.56K ]
(=) Working Capital [ $ 21.66M ] LTRN - Working Capital, Last 5 years
$ 12.32M
Minimum
Jun 30, 2025
$ 81.82M
Maximum
Mar 31, 2021
$ 45.79M
Average
$ 46.6M
Median
Working Capital Benchmark AnalysisMarket
The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.5M with a standard deviation of $ 173.86M.
The following table provides additional summary stats:
Working Capital in the Market:
| filtered constituents | 2.78K |
|---|---|
| min | $ -465.2M |
| max | $ 607.04M |
| average | $ 96.5M |
| median | $ 32.21M |
| std | $ 173.86M |